TES Pharma is a research-based biopharmaceutical company, focussed on delivering first in class preclinical candidates for that unlock the potential of novel therapeutic targets and mechanisms. Our pipeline provides new approaches for metabolic diseases and oncology via small molecule therapeutics.
We use cookie to ensure that we give you best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies on the TES Pharma website.OKREAD MORE